Skip to Content

Vanderbilt-Ingram Cancer CenterVanderbilt-Ingram Cancer Center

 
R. Frank  Cornell

R. Frank Cornell, M.D.

Assistant Professor of Medicine (Hematology/Oncology)
Hematologist/Oncologist

  • Appointments
    615-936-8422
    Physicians: 1-877-936-8422
  • Clinical Trials Information
  • Other Telephone Numbers
    Division of Hematology/Oncology
    615-322-4967

    Henry-Joyce Cancer Clinic
    615-936-8422 or 1-877-936-8422

    Nashville Veterans Affairs Medical Center
    615-327-4751

  • Faxes
    Division of Hematology/Oncology Fax
    615-343-7602
    Henry-Joyce Cancer Clinic Fax
    615-343-8668
    Nashville Veterans Affairs Medical Center Fax
    615-873-7901
  • Addresses
    Clinic
    Vanderbilt University Medical Center
    Division of Hematology/Oncology
    1301 Medical Center Drive, 3927 TVC
    Nashville, TN 37232-5505

    Division of Hematology/Oncology
    2220 Pierce Ave, 777 PRB
    Nashville, TN 37232-6307
    Website

    Henry-Joyce Cancer Clinic
    1301 Medical Center Drive, Suite 1710
    Nashville, Tennessee 37232-7415
    Website

    Nashville Veterans Affairs Medical Center
    1310 24th Ave. South
    Nashville , TN 37212-2637
    Website

Profile

Dr. Cornell is an assistant professor of medicine. He received a B.S. in clinical laboratory science from Saint Louis University and then worked in clinical and molecular hematology at Johns Hopkins Hospital.
Read more ....

Dr. Cornell is an assistant professor of medicine. He received a B.S. in clinical laboratory science from Saint Louis University and then worked in clinical and molecular hematology at Johns Hopkins Hospital. He attended medical school at Trinity College in Dublin, Ireland. Dr. Cornell then completed his Internal Medicine Residency and Hematology/Oncology Fellowship at The Medical College of Wisconsin. He obtained his Master's in Clinical and Translational Science.He specializes in the treatment of plasma cell disorders including Multiple Myeloma, Smoldering Myeloma, Monoclonal Gammopathy of Undetermined Significance (MGUS), POEMS syndrome, Amyloid Light-Chain (AL) Amyloidosis, Plasma Cell Leukemia, Solitary Plasmacytoma and Waldenstrom Macroglobulinemia.Dr. Cornell's research focuses on translational and early phase clinical trials for the treatment of multiple myeloma. He also conducts research and clinical trials for relapsed/refractory multiple myeloma and other plasma cell disorders. He also researches cardio-oncology to better understand the effects of chemotherapy on the heart and vascular system.Dr. Cornell is an active member of the American Society of Hematology, American Society of Clinical Oncology, International Society of Cardio-Oncology, and the American Society for Blood and Marrow Transplantation. He is a member of the multiple myeloma subcommittee of ASBMT.

Education
  • Saint Louis University, B.S. (Clinical Laboratory Science), 2000
  • Trinity College Dublin Medical School, M.D., 2007
  • Internship/Residency - Internal Medicine, Medical College of Wisconsin, 2010
  • Fellowship - Hematology/Oncology, Medical College of Wisconsin, 2013
  • Master of Clinical and Translational Science, Medical College of Wisconsin, 2014
 
Publications